AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Antipsychotic Effects: Methotrimeprazine maleate is commonly prescribed to manage psychotic disorders such as schizophrenia. It exerts its antipsychotic effects by blocking dopamine receptors in the brain, particularly dopamine D2 receptors. This helps alleviate symptoms such as hallucinations, delusions, and disorganized thinking.
Antiemetic Effects: Methotrimeprazine maleate is also used to control severe nausea and vomiting, particularly in patients undergoing chemotherapy or experiencing postoperative nausea and vomiting. Its antiemetic properties are thought to be mediated by its antagonism of dopamine receptors in the chemoreceptor trigger zone (CTZ) and gastrointestinal tract.
Sedation: Methotrimeprazine maleate has sedative effects and is often used to manage agitation or anxiety in psychiatric patients. It can induce drowsiness and promote sleep, which may be beneficial for patients with insomnia or agitation.
Extrapyramidal Side Effects: Like other typical antipsychotic medications, methotrimeprazine maleate can cause extrapyramidal side effects (EPS), including dystonia, akathisia, parkinsonism, and tardive dyskinesia. These side effects result from dopamine receptor blockade in the basal ganglia and can be distressing for patients.
Orthostatic Hypotension: Methotrimeprazine maleate can cause orthostatic hypotension, a drop in blood pressure upon standing up from a lying or sitting position. This effect is due to its alpha-adrenergic blocking properties, which can lead to dilation of blood vessels and reduced vascular tone.
Anticholinergic Effects: Methotrimeprazine maleate has anticholinergic properties, which can manifest as dry mouth, constipation, blurred vision, urinary retention, and cognitive impairment. These side effects are mediated by its blockade of muscarinic acetylcholine receptors.
Cardiac Effects: Methotrimeprazine maleate may prolong the QT interval on electrocardiogram (ECG), increasing the risk of arrhythmias, including torsades de pointes. Therefore, caution is warranted when prescribing methotrimeprazine maleate to patients with preexisting cardiac conditions or those taking other medications that also prolong the QT interval.
Metabolic Effects: Long-term use of methotrimeprazine maleate may be associated with metabolic effects such as weight gain, dyslipidemia, and glucose intolerance, which are common with many antipsychotic medications.
Neuroleptic Malignant Syndrome (NMS): Methotrimeprazine maleate, like other antipsychotics, carries a risk of causing neuroleptic malignant syndrome, a rare but potentially life-threatening condition characterized by hyperthermia, muscle rigidity, autonomic dysfunction, altered mental status, and elevated creatine phosphokinase levels.
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.